There have been many advancements in the treatment and diagnosis of lupus. With proper care and a healthy lifestyle many people with lupus can live a normal life. When lupus is fatal, it’s usually due ...

Did you know that your dog’s nose could be as unique as a human fingerprint? Scientists have discovered that each dog has a distinct nose print pattern that can be used for identification ...

Or maybe you love to hunt cottontail rabbits and, in your dream, the perfect dog is a beagle. A hard-hunting dog that never gives up, always trying to puzzle out the trail and push the rabbit to ...

Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...

Listen to more stories on the Noa app. Lupus, doctors like to say, affects no two patients the same. The disease causes the immune system to go rogue in a way that can strike virtually any organ ...

Lara Vukelich is a freelance writer in San Diego, California. She writes creative content and SEO-driven copy that can be found everywhere from Huffington Post and Quiet Revolution to Expedia ...

For two years, Halsey managed to keep their dual diagnosis of lupus and a rare T-cell lymphoproliferative disorder a secret from their audience. During that time, they performed more than a dozen ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

Not content with getting the first lupus drug to market in the form of the blockbuster Benlysta more than a decade ago, GSK is handing over $300 million in upfront cash for a clinical-stage T-cell ...

GSK will pay $300 million to acquire a bispecific antibody from Shanghai-based Chimagen Biosciences that it believes has the potential to treat autoimmune diseases like lupus. The drug, which is ...